ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
Mohd. Imran1,2 , Abida1, Ruqiah Mohammed Ahmed Alshahrani3, Ahmed Saleh Alanazi4, Khalid Ibrahim Alnafisah5, Shahed Ali Mohammed Alghorayed6, Sumaih Saeed Alsaeed7, Abuzer Ali8, Abdulaziz Khalaf Alshammari9 and Ho Soon Min10
1Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia.
2Center for Health Research, Northern Border University, Arar, Saudi Arabia.
3Health Management Specialist in Bed Management, Abha Maternity and Children Hospital, Abha 62581, Saudi Arabia.
4Dr. Sulaiman Al-Habib Medical Group, Alyasmin, Alriyadh 13322, Saudi Arabia.
5Adel Pharmacies Group, Al-badaya, Al-Qassim 56353, Saudi Arabia.
6Laboratory Specialist, NEOM Hospital, Sharma 49626, Saudi Arabia.
7College of Pharmacy, Qassim University, Qassim Region 52382, Saudi Arabia.
8Department of Pharmacognosy, College of Pharmacy, Taif University, P.O. Box 11099, Taif 1944 Saudi Arabia.
9Al-Dawaa Medical Services Company, Eastern Province, Khobar 34435, Saudi Arabia.
10Faculty of Health and Life Sciences, INTI International University, Putra Nilai, 71800, Negeri Sembilan, Malaysia.
Article Number: 9958 | © The Author(s). 2025
J Pure Appl Microbiol. 2025;19(1):275-287. https://doi.org/10.22207/JPAM.19.1.18
Received: 04 October 2024 | Accepted: 13 November 2024 | Published online: 10 February 2025
Issue online: March 2025
Abstract

Millions of people have died due to coronavirus infection, which has also brought an unparalleled global health crisis to the verge of collapsing several nations healthcare system. The host genetic landscape is becoming more widely acknowledged as a crucial determinant of susceptibility to infection among all other factors. It is still unclear how exactly they are related, though. As a result, we looked into the significance of genetic factors in COVID-19 patients’ severity by performing a thorough analysis of research that were documented in the literature. A thorough search of PubMed was started at the beginning of July 2021. From December 2019 to July 2021, we retrieved all pertinent papers and screened on inclusion and exclusion criteria. This systematic review comprised twenty-five papers with COVID-19 case studies for qualitative synthesis. Seven different gene types, including human leukocyte antigen (HLA), angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), ABO, Cluster of differentiation 45 (CD45), open reading frame (ORF) and interleukin-6 (IL-6) genes were identified, which might be responsible for the significance of coronavirus illness in the patients. Overall, individuals with COVID-19 who also possess the aforementioned genes are at a higher risk of developing significant illness. Still, more information is needed to draw a reliable conclusion.

Keywords

SARS-CoV-2, Genetics, ACE, IL-6, Gene, Mortality, Disease, Illness

Article Metrics

Article View: 213

Share This Article

© The Author(s) 2025. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.